AFM13 in patients with relapsed or refractory Hodgkin Lymphoma: Final results of an open-label, randomized, multicenter phase II trial-MedSci.cn

AFM13 in patients with relapsed or refractory Hodgkin Lymphoma: Final results of an open-label, randomized, multicenter phase II trial

Momotow, J; Sasse, S; Plutschow, A; Huttmann, A; Basara, N; Konecke, C; Martin, S; Bentz, M; Grosse-Thie, C; Thorspecken, S; de Wit, M; Kobe, C; Dietlein, M; von Tresckow, B; Fuchs, M; Borchmann, P; Engert, A

ONCOLOGY RESEARCH AND TREATMENT, 2020; 43 (SUPPL 4): 89

科室
- - 订阅+
  - 更多科室
工具
服务